Navigation Links
Halozyme Begins Randomized, Controlled Clinical Trial with PEGPH20 in Patients with Advanced Pancreatic Cancer
Date:10/5/2011

SAN DIEGO, Oct. 5, 2011 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the diabetes, cancer, dermatology and drug delivery markets, today announced the commencement of patient dosing in a Phase 2 clinical trial with pegylated rHuPH20 (PEGPH20) in patients with stage IV previously untreated pancreatic cancer. This multi-center, international, randomized, placebo-controlled trial will study the safety, tolerability and efficacy of gemcitabine plus PEGPH20 compared to gemcitabine plus placebo.

(Logo: http://photos.prnewswire.com/prnh/20100302/LA63139LOGO)

"Pancreas cancer continues to be an extremely challenging disease for both patients and physicians alike and, unfortunately, most patients with pancreas cancer live less than one year from the time of diagnosis," said Sunil R. Hingorani, M.D., Ph.D. of the Fred Hutchinson Cancer Research Center, a pancreas cancer biologist and principal investigator for the trial. "However, a number of recent observations from both preclinical and early Phase 1 clinical studies suggest that PEGPH20 may render pancreas cancers more susceptible to conventional chemotherapy by depleting the tumor stroma of hyaluronan, improving vascular perfusion and preferentially increasing drug delivery to the tumor bed."

The trial, which includes a single arm run-in stage, will evaluate gemcitabine plus PEGPH20 compared to gemcitabine plus placebo in patients with previously untreated metastatic pancreatic ductal adenocarcinoma. In the Phase 2 portion, patients will be randomized to receive either PEGPH20 plus gemcitabine or placebo plus gemcitabine, respectively. Over 140 patients are expected to be enrolled gl
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. ViroPharma and Halozyme Therapeutics Announce Initiation of Phase 2 Evaluation of Subcutaneous Delivery of Cinryze® (C1 Esterase Inhibitor [Human]) with Hyaluronidase (rHuPH20)
2. Halozyme Therapeutics to Present at Upcoming Financial Conferences
3. Halozyme Therapeutics to Present at the Wedbush 2011 Global Healthcare Conference on August 17
4. Halozymes Ultrafast Insulin Demonstrates Reduced Variability of Insulin Absorption for Type 1 Diabetes Patients Using Insulin Pumps
5. Halozyme and Intrexon Announce Collaboration to Develop First Subcutaneous Recombinant Alpha 1-Antitrypsin Replacement Therapy
6. Halozyme Therapeutics and ViroPharma Announce $83 Million Global Licensing Agreement to Develop Subcutaneous Cinryze® (C1 esterase inhibitor [human])
7. ViroPharma and Halozyme Announce Collaboration for Combination of Recombinant Human Hyaluronidase Enzyme (rHuPH20) Technology with C1 Esterase Inhibitor
8. Halozyme Therapeutics to Present at the Bank of America Merrill Lynch Health Care Conference on May 12
9. Halozyme Therapeutics to Host First Quarter 2011 Financial Results Conference Call on May 6
10. Halozyme Therapeutics Reports Fourth Quarter and Year End 2010 Financial Results
11. Halozyme Therapeutics to Host Fourth Quarter and 2010 Financial Results Conference Call on March 11
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... LAVAL, Quebec , July 14, 2014 /PRNewswire/ ... VRX and TSX: VRX) today announced it ... Antitrust Improvements Act of 1976 (HSR) with the ... proposed acquisition of Allergan, Inc. (NYSE: AGN). ... Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) ...
(Date:7/14/2014)... Francisco, Calif. , July 14, 2014 ... today announces a technology partnership with global ... develop its technology for quick-to-market products. ... approach and DNA2.0,s machine learning optimization technologies, ... speeding up the process of engineering proteins ...
(Date:7/14/2014)... PARK, Ill., July 14, 2014  Abbott (NYSE: ... branded generics pharmaceuticals business to Mylan for equity ownership ... existing business and Abbott,s developed ... company. This represents a value of approximately $5.3 billion ... developed markets portion of this business generated approximately $2 ...
Breaking Medicine Technology:Valeant Pharmaceuticals Submits HSR Filing Relating To Proposed Acquisition Of Allergan 2Valeant Pharmaceuticals Submits HSR Filing Relating To Proposed Acquisition Of Allergan 3Valeant Pharmaceuticals Submits HSR Filing Relating To Proposed Acquisition Of Allergan 4Valeant Pharmaceuticals Submits HSR Filing Relating To Proposed Acquisition Of Allergan 5Pareto Biotechnologies Announces Technology Partnership With DNA2.0, Inc. 2Pareto Biotechnologies Announces Technology Partnership With DNA2.0, Inc. 3Abbott to Sell its Developed Markets Branded Generics Pharmaceuticals Business to Mylan 2Abbott to Sell its Developed Markets Branded Generics Pharmaceuticals Business to Mylan 3Abbott to Sell its Developed Markets Branded Generics Pharmaceuticals Business to Mylan 4Abbott to Sell its Developed Markets Branded Generics Pharmaceuticals Business to Mylan 5Abbott to Sell its Developed Markets Branded Generics Pharmaceuticals Business to Mylan 6Abbott to Sell its Developed Markets Branded Generics Pharmaceuticals Business to Mylan 7
... Colo., May 19, 2011 In response to growing concerns ... children and the recent FDA Guidance for Industry ... provider of oral liquid drug delivery syringes, is available to ... at home and in hospitals: ...
... Swissray International, Inc., a leading manufacturer of direct digital Radiography ... another ddR Formula DR system to the ... more than a decade Swissray has been the pioneer and ... ) serving hundreds of health care providers and patients with ...
Cached Medicine Technology:Medication Delivery Innovator Baxa Corporation Offers Best Practices for Administering Over-the-Counter Liquid Medicine to Babies and Toddlers 2Medication Delivery Innovator Baxa Corporation Offers Best Practices for Administering Over-the-Counter Liquid Medicine to Babies and Toddlers 3Swissray Sells Another DR System to a Large Orthopedic Practice in Florida 2
(Date:7/14/2014)... Seven promising startup companies developing online, ... been accepted into the University City Science ... , The awardees were selected from a pool ... include Biomeme, Fitly, Life Patch, Curbside Care, UE ... Pulse InfoFrame (from Canada) —both of which will ...
(Date:7/14/2014)... According to a new market research ... SiC, and Others), Devices (Power IC, Power Module & ... to 2014 - 2020", the Power Electronics market is ... electronics market is valued at $36.86 Billion and expected ... 2020. The report also includes an in-depth analysis of ...
(Date:7/14/2014)... (PRWEB) July 14, 2014 This ... valves market in Americas. The analysis includes market ... 2007–2020 period and key company share data by ... Canada, Brazil and Mexico. It uses data and ... research and in-house analysis. , Scope, ...
(Date:7/14/2014)... -- Along with improving vision, cataract surgery may slow ... types of dementia, a new study suggests. Better ... said. "These preliminary results indicate that improved vision ... dementia and their loved ones, both visual and non-visual," ... and University Hospitals Case Medical Center, in Ohio. ...
(Date:7/14/2014)... HealthDay Reporter MONDAY, July ... linked to multiple health issues, but dementia isn,t one of ... widowhood may even delay dementia, the researchers found. "For ... was associated with a later age of developing full-blown dementia ... Bryan Woodruff. Woodruff, an assistant professor of neurology ...
Breaking Medicine News(10 mins):Health News:Seven Healthcare Startups Selected to Participate in University City Science Center’s First Digital Health Accelerator 2Health News:Seven Healthcare Startups Selected to Participate in University City Science Center’s First Digital Health Accelerator 3Health News:Seven Healthcare Startups Selected to Participate in University City Science Center’s First Digital Health Accelerator 4Health News:Power Electronics Market Estimated to Reach $36.86 Billion by 2020 at CAGR of 7.74% - New Report by MarketsandMarkets 2Health News:Power Electronics Market Estimated to Reach $36.86 Billion by 2020 at CAGR of 7.74% - New Report by MarketsandMarkets 3Health News:Power Electronics Market Estimated to Reach $36.86 Billion by 2020 at CAGR of 7.74% - New Report by MarketsandMarkets 4Health News:Power Electronics Market Estimated to Reach $36.86 Billion by 2020 at CAGR of 7.74% - New Report by MarketsandMarkets 5Health News:Americas Transcatheter Heart Valves Market 2020 Forecasts in New Research Report at LifeScienceIndustryResearch.com 2Health News:Americas Transcatheter Heart Valves Market 2020 Forecasts in New Research Report at LifeScienceIndustryResearch.com 3Health News:Americas Transcatheter Heart Valves Market 2020 Forecasts in New Research Report at LifeScienceIndustryResearch.com 4Health News:Cataract Surgery a Plus for Someone With Dementia, Study Says 2Health News:Widowhood May Delay Dementia in Some Seniors, Study Finds 2Health News:Widowhood May Delay Dementia in Some Seniors, Study Finds 3
... didn,t seem to matter, study finds , TUESDAY, Oct. 6 ... a deadly form of brain tumor in adulthood, new research ... the teen years was associated with a lower risk of ... increased the chances of such malignancies. , The study appears ...
... (NYSE: LLY ) will announce its financial results for the ... will also conduct a conference call on that day with the ... , The conference call will be held from 9:00 a.m. ... can access a live webcast of the conference call through a ...
... SEATTLE, Oct. 6 While end-of-life care issues have ... reform debate, physicians in the Pacific Northwest can now ... palliative medicine and hospice care. , The new Palliative ... the state of Washington, is a cooperative effort between ...
... Youths, thinner skin makes them more susceptible to severe injury, expert ... day last year, Danette McKinney asked her husband, Shawn, to check ... the door, Shawn didn,t see their 1-year-old daughter toddle up beside ... and shrieked. , "As we were taking her to the hospital, ...
... ... PetDocsOnCall.com is a new virtual pet lover,s community with something for ... direction from practicing veterinarians and specialists. Pet owners can post non-emergency ... quickly. Best of all, PetDocsOnCall.com users can feel secure knowing the ...
... CHICAGO, Oct. 6 The Blue Cross and Blue Shield ... of Health Care Policy, today recognized six Blue Cross and ... awards for their innovative and successful approaches to improving ... in its fifth year, the BlueWorks program ...
Cached Medicine News:Health News:Exercise in Adolescence May Cut Risk of Deadly Brain Tumor 2Health News:Exercise in Adolescence May Cut Risk of Deadly Brain Tumor 3Health News:New Palliative Medicine Fellowship Created to Train Pacific Northwest Doctors in End-of-Life Care 2Health News:New Palliative Medicine Fellowship Created to Train Pacific Northwest Doctors in End-of-Life Care 3Health News:Burn Rate in Kids Has Dropped, But Still Causes Concern 2Health News:Burn Rate in Kids Has Dropped, But Still Causes Concern 3Health News:PetDocsOnCall.com Connects Pet Owners to the Largest Online Network of Practicing Veterinarians 2Health News:Blue Cross and Blue Shield Companies Honored for Innovative Programs That Help Consumers Live Healthier Lives 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: